Using Microtiter Dish Radiolabeling for Multiple In Vivo Measurements Of Escherichia coli (p)ppGpp Followed by Thin Layer Chromatography
June 4th, 2019
The growth of radiolabeled bacterial cultures in microtiter dishes facilitates high throughput sampling that allows multiple technical and biological replicate assays of nucleotide pool abundance, including that of (p)ppGpp. The effects of growth transitions provoked by sources of physiological stress as well as recovery from stress can be monitored.
Overview
This study details a method for measuring the levels of the global regulator ppGpp in bacterial cultures under various growth conditions and stress situations. The use of radiolabeled bacterial cultures in microtiter dishes allows for high throughput analysis, giving insights into nucleotide pool abundance during physiological stress and recovery.
Key Study Components
Research Area
- Molecular biology
- Stress physiology in bacteria
- Nucleotide regulation
Background
- PpGpp is a crucial global regulator found in both gram-positive and gram-negative bacteria as well as chloroplasts.
- It has a rapid response to stress and a short half-life, necessitating precise monitoring.
- The study emphasizes safe handling of radioactive materials during experimentation.
Methods Used
- High throughput sampling using radiolabeled bacterial cultures in microtiter dishes
- Monitoring ppGpp levels under stress and recovery conditions
- Thin layer chromatography for analyzing nucleotide levels
Main Results
- Demonstrated an increase in ppGpp levels during isoleucine starvation.
- Showed that ppGpp decays with a half-life of approximately 64 seconds after stress relief.
- Documented the potential to adapt the methodology for a variety of organisms.
Conclusions
- The study provides a valuable method for exploring nucleotide regulation amidst physiological stress.
- It highlights the applicability of this method across different bacterial species in biological research.
Frequently Asked Questions
Executive Industry Relevance
Quantitative measurement of (p)ppGpp dynamics in Escherichia coli under stress and recovery provides critical insight into bacterial adaptation mechanisms. This capability enables high-resolution interrogation of nucleotide pool changes, supporting mechanistic de-risking and target validation in antimicrobial discovery. The approach enhances predictive confidence at the interface of early discovery and translational research for bacterial stress response pathways.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables precise quantification of (p)ppGpp as a functional biomarker for stress response.
- Supports mechanistic de-risking by resolving rapid nucleotide turnover during stress transitions.
- Facilitates target validation for regulators of bacterial adaptation and persistence.
Screening & Assay Development
- Delivers high-throughput, parallel monitoring of radiolabeled cultures for robust assay development.
- Ensures reproducibility and quantitative output through standardized microtiter and TLC workflows.
- Prepares validated biological systems for downstream screening of modulators affecting (p)ppGpp metabolism.
Translational & Preclinical Research
- Aligns with translational biomarker strategies by enabling time-resolved measurement of stress-induced nucleotide changes.
- Supports continuity from discovery to preclinical validation in bacterial stress and persistence models.
- Provides predictive value for risk-adjusted advancement of antibacterial candidates targeting stress pathways.
Pipeline & Workflow Integration
This method integrates at the early discovery and lead identification stages, bridging mechanistic studies with quantitative assay development for bacterial stress response research.
- Discovery Biology: Enables hypothesis testing of stress adaptation mechanisms via real-time (p)ppGpp quantification.
- Screening: Provides reproducible, scalable assay platforms for evaluating compound effects on nucleotide pools.
- Analytics: Delivers quantitative, time-resolved readouts for comparative analysis of stress and recovery conditions.
- Translational Research: Supports biomarker alignment and continuity into preclinical bacterial models.
- Enterprise Reuse: Offers a reusable workflow adaptable to diverse bacterial species and stress paradigms.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in bacterial stress pathway studies.
- Operational Value: Standardizes high-throughput, parallelized measurements for robust data generation.
- Strategic Value: Informs go/no-go decisions for antibacterial target prioritization and resource allocation.
- Portfolio Impact: Enables risk-adjusted prioritization of discovery and preclinical programs targeting bacterial adaptation.
Implementation Considerations
- Requires expertise in radiolabeling, bacterial culture, and thin-layer chromatography.
- Demands access to temperature- and shaker-controlled microtiter incubators and phosphorimaging infrastructure.
- Necessitates rigorous cross-team standardization for sample handling and data analysis.
- Adaptable across gram-negative and gram-positive bacterial models with protocol modifications.
- Strict adherence to radioactive safety protocols is essential for operational compliance.
Biopharma FAQs
Chapters in this video
0:04
Title
0:47
Labeling with 32P
2:11
Induction of Stress or Starvation and Sample and ppGpp Extraction
2:54
Thin-layer Chromatography and Quantitation of (p)ppGpp
4:13
Measurement of the Rate of ppGpp Decay
4:46
Results: In Vivo Measurements of Escherichia coli
5:51
Conclusion
